One of the main regulators of lnc-DHX32-2:1, which targeted for gene ADAM12, has been implicated in a variety of biological processes, including lung cancer and the development of giant cell tumors, and positively involved in the regulation of the MAPK/ERK pathway. This evidence concerns the gene DHX32 and lung carcinoma.